{"id":"W2803381821","doi":"10.1007/s00277-018-3365-y","title":"Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis","keywords":"Ruxolitinib; Medicine; Hematocrit; Polycythemia vera; Internal medicine; Hematology; Anemia; Myelofibrosis; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004925707,0.0002913568,0.001458941,0.00007493445,0.0001820612,0.00001198937,0.0001822146,0.0001525177,0.0002114507],"category_scores_gemma":[0.0009109055,0.0001373317,0.0005586649,0.0001061851,0.0004876428,0.00003176265,0.00002494641,0.00007603298,0.00002157665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002601209,"about_ca_system_score_gemma":0.0003016469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000402145,"about_ca_topic_score_gemma":0.0001755079,"domain_scores_codex":[0.9979227,0.0003220333,0.0007881568,0.0003399007,0.0002392807,0.0003879641],"domain_scores_gemma":[0.9915915,0.006836247,0.0004874608,0.0006598037,0.0003274832,0.00009749729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.9451178,0.003374157,0.01615308,0.00003623369,0.004809155,0.0000301394,0.004211647,7.110796e-7,0.001527563,0.01034594,0.009944198,0.004449415],"study_design_scores_gemma":[0.4167392,0.05813795,0.01625536,0.0002228116,0.002209814,0.00009182542,0.001171723,0.0001974637,0.4273775,0.003254301,0.07401513,0.0003269565],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9599804,0.003285988,0.00007234743,0.03201449,0.0004748606,0.003532198,0.0002310069,0.00001932495,0.0003894255],"genre_scores_gemma":[0.99586,0.000582026,0.0002288111,0.001285247,0.0004677183,0.001076808,0.00004704287,0.00002911636,0.000423194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5283785,"threshold_uncertainty_score":0.5600224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1235891608295298,"score_gpt":0.3813806818075789,"score_spread":0.2577915209780491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}